References are publications that support the biological activity of the product
The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders.
Jeon WJ et al (2013) Prog Neuropsychopharmacol Biol Psychiatry 47 : 7-12.
Differential coupling of muscarinic m2 and m3 receptors to adenylyl cyclases V/VI in smooth muscle. Concurrent M2-mediated inhibition via Galphai3 and m3-mediated stimulation via Gbetagammaq.
Murthy KS et al (1997) J Biol Chem 272(34) : 21317-24.
Regional binding of 4-diphenylacetoxy-N-methylpiperidine methobromide (4-DAMP) to muscarinic receptors in rat brain and comparative analysis of minimum energy conformations.
Collins D et al (1993) Neurochem Int 22(3) : 237-47.